<?xml version="1.0" encoding="UTF-8"?>

<Composition xmlns="http://hl7.org/fhir">
  <id value="CoreNeedleBiopsyComposition"/>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Composition CoreNeedleBiopsyComposition</b></p><a name="CoreNeedleBiopsyComposition"> </a><a name="hcCoreNeedleBiopsyComposition"> </a><p><b>identifier</b>: Accession ID/PATH-COMP-2024-001</p><p><b>status</b>: Final</p><p><b>type</b>: <span title="Codes:{http://ihe-d.de/CodeSystems/IHEXDStypeCode PATH}, {http://snomed.info/sct 721967005}">Tissue pathology biopsy report</span></p><p><b>encounter</b>: <a href="Encounter-CoreNeedleBiopsyEncounter.html">Encounter: identifier = http://example.hospital.de/encounters#E_24_001; status = finished; class = IMB (IMB)</a></p><p><b>date</b>: 2024-01-20 15:30:00+0100</p><p><b>author</b>: <a href="Organization-PathologyLabOrganization.html">Pathologisches Institut</a></p><p><b>title</b>: Histopathologischer Befundbericht - Prostatabiopsie</p><h3>Attesters</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Mode</b></td><td><b>Party</b></td></tr><tr><td style="display: none">*</td><td>Legal</td><td><a href="Organization-PathologyLabOrganization.html">Organization Pathologielabor</a></td></tr></table><p><b>custodian</b>: <a href="Organization-PathologyLabOrganization.html">Organization Pathologielabor</a></p><h3>Events</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td><td><b>Detail</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://terminology.hl7.org/CodeSystem/v3-ActCode PATREPE}">pathology report entry task</span></td><td><a href="ServiceRequest-CoreNeedleBiopsyReportRequest.html">ServiceRequest Prostate Pathology biopsy report</a></td></tr></table></div>
  </text>
  <identifier>
    <type>
      <coding>
        <system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
        <code value="ACSN"/>
        <display value="Accession ID"/>
      </coding>
    </type>
    <system value="http://example.hospital.de/pathology-reports"/>
    <value value="PATH-COMP-2024-001"/>
  </identifier>
  <status value="final"/>
  <type>
    <coding>
      <system value="http://ihe-d.de/CodeSystems/IHEXDStypeCode"/>
      <code value="PATH"/>
    </coding>
    <coding>
      <system value="http://snomed.info/sct"/>
      <code value="721967005"/>
      <display value="Tissue pathology biopsy report"/>
    </coding>
  </type>
  <subject>
    <reference value="Patient/Patient1"/>
    <display value="Hans Mueller, geb. 15.08.1955 (PAT-2024-001)"/>
  </subject>
  <encounter>
    <reference value="Encounter/CoreNeedleBiopsyEncounter"/>
  </encounter>
  <date value="2024-01-20T15:30:00+01:00"/>
  <author>
    <reference value="Organization/PathologyLabOrganization"/>
    <display value="Pathologisches Institut"/>
  </author>
  <title value="Histopathologischer Befundbericht - Prostatabiopsie"/>
  <attester>
    <mode value="legal"/>
    <party>
      <reference value="Organization/PathologyLabOrganization"/>
    </party>
  </attester>
  <custodian>
    <reference value="Organization/PathologyLabOrganization"/>
  </custodian>
  <event>
    <code>
      <coding>
        <system value="http://terminology.hl7.org/CodeSystem/v3-ActCode"/>
        <code value="PATREPE"/>
      </coding>
    </code>
    <detail>
      <reference value="ServiceRequest/CoreNeedleBiopsyReportRequest"/>
    </detail>
  </event>
  <section>
    <title value="Pathologiebefundbericht"/>
    <code>
      <coding>
        <system value="http://loinc.org"/>
        <code value="11526-1"/>
        <display value="Pathology study"/>
      </coding>
    </code>
    <text>
      <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml"><h3>Klinische Angaben</h3><p>Erhöhter PSA-Wert (8,5 ng/ml). V.a. Prostatakarzinom. Bitte histologische Abklärung.</p><h3>Makroskopie</h3><table border="1" cellpadding="4" cellspacing="0"><thead><tr><th>Stanze</th><th>Lokalisation</th><th>Länge (cm)</th><th>Zylinder</th></tr></thead><tbody><tr><td>01</td><td>Rechts lateral basal</td><td>1.8</td><td>1</td></tr><tr><td>02</td><td>Rechts lateral mid</td><td>1.6</td><td>1</td></tr><tr><td>03</td><td>Rechts lateral apikal</td><td>1.5</td><td>1</td></tr><tr><td>04</td><td>Rechts medial basal</td><td>1.9</td><td>1</td></tr><tr><td>05</td><td>Rechts medial mid</td><td>1.4</td><td>1</td></tr><tr><td>06</td><td>Rechts medial apikal</td><td>1.7</td><td>1</td></tr><tr><td>07</td><td>Links lateral basal</td><td>1.6</td><td>1</td></tr><tr><td>08</td><td>Links lateral mid</td><td>1.5</td><td>1</td></tr><tr><td>09</td><td>Links lateral apikal</td><td>1.8</td><td>1</td></tr><tr><td>10</td><td>Links medial basal</td><td>1.3</td><td>1</td></tr><tr><td>11</td><td>Links medial mid</td><td>1.7</td><td>1</td></tr><tr><td>12</td><td>Links medial apikal</td><td>1.4</td><td>1</td></tr></tbody></table><h3>Mikroskopie</h3><table border="1" cellpadding="4" cellspacing="0"><thead><tr><th>Stanze</th><th>Befund</th><th>Gleason</th><th>Tumoranteil</th></tr></thead><tbody><tr><td>01</td><td>Adenokarzinom</td><td>3+4=7</td><td>40%</td></tr><tr><td>02</td><td>Adenokarzinom</td><td>4+3=7</td><td>60%</td></tr><tr><td>03</td><td>Benigne</td><td>-</td><td>-</td></tr><tr><td>04</td><td>Adenokarzinom</td><td>4+4=8</td><td>80%</td></tr><tr><td>05</td><td>Benigne</td><td>-</td><td>-</td></tr><tr><td>06</td><td>Adenokarzinom</td><td>3+3=6</td><td>20%</td></tr><tr><td>07</td><td>Adenokarzinom</td><td>4+5=9</td><td>95%</td></tr><tr><td>08</td><td>Benigne</td><td>-</td><td>-</td></tr><tr><td>09</td><td>Adenokarzinom</td><td>3+4=7</td><td>35%</td></tr><tr><td>10</td><td>Benigne</td><td>-</td><td>-</td></tr><tr><td>11</td><td>Adenokarzinom</td><td>3+4=7</td><td>25%</td></tr><tr><td>12</td><td>Benigne</td><td>-</td><td>-</td></tr></tbody></table><h3>Diagnostische Schlussfolgerung</h3><p><b>Diagnose:</b> Azinäres Adenokarzinom der Prostata (ICD-O 8140/3)</p><table border="1" cellpadding="4" cellspacing="0"><tbody><tr><td>Histologischer Typ</td><td>Azinäres Adenokarzinom (8140/3)</td></tr><tr><td>Gleason-Score</td><td>4+5=9 (höchster Score)</td></tr><tr><td>ISUP-Gradgruppe</td><td>5 (WHO 2016)</td></tr><tr><td>Positive Stanzen</td><td>7 von 12 (4 rechts, 3 links)</td></tr><tr><td>Tumoranteil gesamt</td><td>51%</td></tr><tr><td>Tumorlänge gesamt</td><td>52,7 mm</td></tr><tr><td>Anteil Gleason 4/5</td><td>77%</td></tr><tr><td>Perineurale Infiltration</td><td>Nachgewiesen</td></tr><tr><td>Periprostatische Fettinvasion</td><td>Nachgewiesen (apikal)</td></tr><tr><td>Samenblaseninfiltration</td><td>Nicht nachgewiesen</td></tr><tr><td>Lymphovaskuläre Invasion</td><td>Nicht nachgewiesen</td></tr><tr><td>Intraduktales Karzinom</td><td>Nicht nachgewiesen</td></tr><tr><td>ASAP</td><td>Nein</td></tr><tr><td>High-grade-PIN</td><td>Nicht nachgewiesen</td></tr></tbody></table></div>
    </text>
    <entry>
      <reference value="DiagnosticReport/CoreNeedleBiopsyReport"/>
    </entry>
  </section>
</Composition>